vtgn stock forecast cnn

VistaGen Therapeutics Inc. Find real-time VTGN - VistaGen Therapeutics Inc stock quotes company profile news and forecasts from CNN Business.

Penny Stocks To Watch Before March 2021

Dividend Date P-E EPS Earnings Date 051122.

. Volume 100-day 1219636 Market Cap 291204417 Days Range 14 - 149 52-week Range 138 - 355 Dividend Yield Ex. Based on our forecasts a long-term increase is expected the VTGN stock price prognosis for 2027-02-12 is 6799 USD. Vistagen Therapeutics Inc NASDAQ Updated Feb 19 2022 1244 AM.

The average twelve-month price target for VistaGen Therapeutics is 900 with a high price target of 900 and a low price target of 900. Your current 100 investment may be up to 42893 in 2027. 40 OFF - NEW YEAR SALE Get Our PREMIUM Now.

07 2022 globe newswire -- vistagen therapeutics inc. 52630M Enterprise Value 41555M Net Profit Margin -164609 PEG PriceEarnings Growth Ratio - Beta 097 Forward PE -1023 PriceSales 000. VTGN is a clinical-stage biopharmaceutical company committed to developing and commercializing new generation medications that go beyond the current standard of care for anxiety depression and other central nervous system CNS disorders.

Given the current short-term trend the stock is expected to fall -2476 during the next 3 months and with a 90 probability hold a price between 099 and 137 at the end of this 3-month period. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Vtgn a biopharmaceutical company committed to developing and commercializing innovative.

VTGN Vistagen Therapeutics Inc Stock Price and Discussion Stocktwits. 109M Net Income -4232M Market Cap. See VistaGen Therapeutics Inc.

South san francisco calif feb. VTGN stock analyst estimates including earnings and revenue EPS upgrades and downgrades. According to the issued ratings of 1 analysts in the last year the consensus rating for VistaGen Therapeutics stock is Buy based on the current 1 buy rating for VTGN.

Coverage of premarket trading including futures information for the SP 500 Nasdaq Composite and Dow Jones Industrial Average. VistaGen Therapeutics Stock Forecast Price News 133 -003 -221 As of 02232022 1200 AM ET Todays Range 132 146 50-Day Range 136 209 52-Week Range 132 355 Volume 102 million shs Average Volume 121 million shs Market Capitalization 27468 million PE Ratio NA Dividend Yield NA Beta 089 Profile Analyst Ratings. Based on analysts offering 12 month price targets for VTGN in the last 3 months.

With a 5-year investment the revenue is expected to be around 32893. The average price target is 000 with a high estimate of 000 and a low estimate of 000. - Try Now Risk-Free - Money-back guarantee.

Com VTGN Analyst Forecast VTGN Price Volume Earnings and Dividend Date Last Price 139 Previous Close 139 Change 000 Open 145 Volume 1215700 Avg. Common Stock VTGN Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. VTGN 139 008 544 Post-Market 005 360 14780.

Our CNS portfolio includes three differentiated drug candidates.

A Thorough Dd On Vtgm Vistagen R Educatedinvesting